scholarly article | Q13442814 |
P2093 | author name string | S Tiwari | |
S Singh | |||
R Singh | |||
S Dwivedi | |||
A Ghatak | |||
K S Saini | |||
R Konwar | |||
A K Madeshiya | |||
P2860 | cites work | Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice. | Q46345972 |
Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-->G promoter polymorphism | Q46623843 | ||
The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia | Q46672467 | ||
Insulin regulation of MCP-1 in human adipose tissue of obese and lean women | Q46757566 | ||
Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study | Q46774747 | ||
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). | Q46923440 | ||
Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters | Q46988914 | ||
Association of monocyte chemoattractant protein-1 -2518 polymorphism with metabolic syndrome in a South Indian cohort. | Q47778476 | ||
Variation of serum monocyte chemoattractant protein-1 in patients with diabetes and metabolic syndrome. | Q51372103 | ||
Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. | Q53556065 | ||
Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: Evidence for susceptibility loci on 1q | Q57073109 | ||
Chemokines control fat accumulation and leptin secretion by cultured human adipocytes | Q57076426 | ||
Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study | Q28268514 | ||
MCP-1 (monocyte chemotactic protein-1)-induced protein, a recently identified zinc finger protein, induces adipogenesis in 3T3-L1 pre-adipocytes without peroxisome proliferator-activated receptor gamma | Q28506501 | ||
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
Gene variants of monocyte chemoattractant protein 1 and components of metabolic syndrome in KORA S4, Augsburg | Q33275498 | ||
Genetics of the metabolic syndrome | Q33964734 | ||
Chemokines, leukocytes, and atherosclerosis | Q34005747 | ||
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels | Q34161535 | ||
Metabolic syndrome: definitions and controversies. | Q35047747 | ||
Monocyte chemoattractant protein 1 in obesity and insulin resistance | Q35163496 | ||
The metabolic syndrome: prevalence in worldwide populations | Q35781478 | ||
Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants | Q36356057 | ||
Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals | Q37400830 | ||
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis | Q42170189 | ||
Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients | Q44574645 | ||
Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality | Q44599748 | ||
Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome | Q44777046 | ||
Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus | Q45045301 | ||
Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients | Q45166628 | ||
P433 | issue | 2 | |
P921 | main subject | India | Q668 |
metabolic syndrome | Q657193 | ||
anthropometry | Q6656244 | ||
P304 | page(s) | 78-86 | |
P577 | publication date | 2015-01-30 | |
P1433 | published in | International Journal of Immunogenetics | Q15755115 |
P1476 | title | Monocyte chemoattractant protein-1 gene polymorphism and its serum level have an impact on anthropometric and biochemical risk factors of metabolic syndrome in Indian population. | |
P478 | volume | 42 |
Search more.